FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer
for Breast Cancer
7 locations incl. La Jolla
Sponsor: Regor Pharmaceuticals Inc.
Sex: All·Age: 18+
Code: NCT05304962·Phase 1·Recruiting·Listed Mar 2022